BACE1 and Alzheimer disease: Over the last two decades, BACE1 has been attracting the interest of several clinical researchers due to its role in amyloid-beta (Aβ) homeostasis, and its potentials as pharmacological target and diagnostic/prediction biomarker of AD [24, 25].